We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

323 hedge funds and large institutions have $11.5B invested in Vaxcyte in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 139 increasing their positions, 90 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $48.1M | Put options by funds: $25.7M

54% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 90

0.88% more ownership

Funds ownership: 112.07% → 112.96% (+0.88%)

0% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 62

2% less funds holding

Funds holding: 328 → 323 (-5)

26% less capital invested

Capital invested by funds: $15.6B → $11.5B (-$4.07B)

48% less funds holding in top 10

Funds holding in top 10: 23 → 12 (-11)

Holders
323
Holders Change
-5
Holders Change %
-1.52%
% of All Funds
4.25%
Holding in Top 10
12
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-47.83%
% of All Funds
0.16%
New
62
Increased
139
Reduced
90
Closed
62
Calls
$48.1M
Puts
$25.7M
Net Calls
+$22.4M
Net Calls Change
-$6.81M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$217M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$130M
3
KCM
Kynam Capital Management
New Jersey
+$129M
4
State Street
State Street
Massachusetts
+$113M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$82.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$269M
2
DGM
Darwin Global Management
Jersey
-$251M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$118M
4
FAM
Fred Alger Management
New York
-$71.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$57.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AM
151
AGF Management
Ontario, Canada
$2.33M +$2.82M +28,444 New
Canada Life
152
Canada Life
Manitoba, Canada
$2.32M +$538K +5,423 +24%
State Board of Administration of Florida Retirement System
153
State Board of Administration of Florida Retirement System
Florida
$2.19M – – –
PFSRSONJ
154
Police & Firemen's Retirement System of New Jersey
New Jersey
$2.17M +$2.63M +26,455 New
GC
155
Guggenheim Capital
Illinois
$2.17M -$333K -3,350 -11%
CUAMC
156
China Universal Asset Management Company
China
$2.16M +$493K +4,962 +23%
MOACM
157
Mutual of America Capital Management
New York
$2.07M -$2.49M -25,071 -50%
AAA
158
Affinity Asset Advisors
New York
$2.05M -$2.48M -25,000 -50%
BAMCO Inc
159
BAMCO Inc
New York
$2.05M -$596K -6,000 -19%
AQR Capital Management
160
AQR Capital Management
Connecticut
$2.01M +$1.33M +13,403 +121%
Bank of Montreal
161
Bank of Montreal
Ontario, Canada
$1.95M -$353K -3,560 -13%
CP
162
CenterBook Partners
Connecticut
$1.91M +$2.32M +23,367 New
KK
163
KLP Kapitalforvaltning
Norway
$1.84M +$2.23M +22,500 New
PAP
164
Persistent Asset Partners
Hong Kong
$1.69M +$1.9M +19,151 New
DekaBank Deutsche Girozentrale
165
DekaBank Deutsche Girozentrale
Germany
$1.67M – – –
SSA
166
Schonfeld Strategic Advisors
New York
$1.67M -$6.02M -60,610 -75%
BCM
167
Bayesian Capital Management
New York
$1.65M +$2.01M +20,204 New
Twin Tree Management
168
Twin Tree Management
Texas
$1.58M +$1.55M +15,588 +417%
SAM
169
Sectoral Asset Management
Quebec, Canada
$1.55M +$438K +4,410 +30%
TRSOTSOK
170
Teachers Retirement System of the State of Kentucky
Kentucky
$1.54M -$247K -2,489 -12%
SO
171
STRS Ohio
Ohio
$1.51M -$705K -7,100 -28%
CFM
172
Catalyst Funds Management
Australia
$1.51M +$29.8K +300 +2%
HSBC Holdings
173
HSBC Holdings
United Kingdom
$1.45M +$441K +4,443 +33%
DT
174
Diversified Trust
Tennessee
$1.43M +$1.74M +17,502 New
GGHC
175
Gilder Gagnon Howe & Co
New York
$1.35M +$4.17K +42 +0.3%
5 6
7
8 9

PCVX Hedge Fund Activity: Q4 2024 in Review

323 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2024, worth a combined $11.5B — down 26% from $15.6B a quarter earlier.

Fund positioning in PCVX was balanced in Q4 2024: 62 funds opened new positions, 62 closed out, 139 added to existing stakes and 90 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $217M. The largest seller was Fidelity Investments, cutting an estimated $269M.

  • 323 institutional investors held Vaxcyte (PCVX) as of Q4 2024, down from 328 in Q3 2024.
  • Funds reported $11.5B of Vaxcyte stock for Q4 2024, down 26% quarter-over-quarter.
  • 62 funds opened new Vaxcyte positions in Q4 2024 and 62 closed out, a net change of 0 holders.
  • The largest Vaxcyte buyer in Q4 2024 was Goldman Sachs, an estimated $217M added.
  • The largest Vaxcyte seller in Q4 2024 was Fidelity Investments, an estimated $269M sold.

Based on aggregated 13F filings for Q4 2024.